rs17685379
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_003954.5(MAP3K14):c.1291-89G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 1,476,580 control chromosomes in the GnomAD database, including 10,998 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.099 ( 931 hom., cov: 32)
Exomes 𝑓: 0.12 ( 10067 hom. )
Consequence
MAP3K14
NM_003954.5 intron
NM_003954.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.305
Genes affected
MAP3K14 (HGNC:6853): (mitogen-activated protein kinase kinase kinase 14) This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-45274682-C-T is Benign according to our data. Variant chr17-45274682-C-T is described in ClinVar as [Benign]. Clinvar id is 2628305.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K14 | NM_003954.5 | c.1291-89G>A | intron_variant | ENST00000344686.8 | NP_003945.2 | |||
MAP3K14 | XM_047436997.1 | c.1291-89G>A | intron_variant | XP_047292953.1 | ||||
MAP3K14 | XM_047436998.1 | c.1291-89G>A | intron_variant | XP_047292954.1 | ||||
MAP3K14 | XM_011525441.3 | c.1291-89G>A | intron_variant | XP_011523743.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K14 | ENST00000344686.8 | c.1291-89G>A | intron_variant | 1 | NM_003954.5 | ENSP00000478552.1 | ||||
MAP3K14 | ENST00000376926.8 | c.1291-89G>A | intron_variant | 1 | ENSP00000482657.1 | |||||
MAP3K14 | ENST00000617331.3 | c.1291-89G>A | intron_variant | 5 | ENSP00000480974.3 | |||||
MAP3K14 | ENST00000680632.1 | n.139-89G>A | intron_variant | ENSP00000505027.1 |
Frequencies
GnomAD3 genomes AF: 0.0995 AC: 15126AN: 152086Hom.: 930 Cov.: 32
GnomAD3 genomes
AF:
AC:
15126
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.121 AC: 159700AN: 1324374Hom.: 10067 AF XY: 0.119 AC XY: 77993AN XY: 653320
GnomAD4 exome
AF:
AC:
159700
AN:
1324374
Hom.:
AF XY:
AC XY:
77993
AN XY:
653320
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0994 AC: 15134AN: 152206Hom.: 931 Cov.: 32 AF XY: 0.0997 AC XY: 7419AN XY: 74408
GnomAD4 genome
AF:
AC:
15134
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
7419
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
392
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 19. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at